Palm Beach Gardens, FL
RECO Immersive / Locations / Palm Beach Gardens

Psychiatric medication management for Palm Beach Gardens — residential-level optimization, 35 minutes away.

A specialist outpatient program for clients in Palm Beach Gardens. PHP, IOP, in-house psychiatry, sober-living network, family programming. Same admissions team, 24/7.

Start the conversation Or call directly — (561) 464-4077
25 mi from Palm Beach Gardens
35 min average drive
24/7 admissions line
Why RECO Immersive from Palm Beach Gardens

Local options exist. This is the clinical specialist.

For a Palm Beach Gardens resident whose depression, anxiety, PTSD, or bipolar disorder has outrun what outpatient med management can measure, RECO Immersive's Delray campus sits 25 miles south — 35 minutes on I-95. The residential setting adds what outpatient cannot: observed adherence, weekly lithium or valproate levels during titration, side-effect capture inside 72 hours, and integrated coordination with concurrent TMS or ketamine at RECO Health. Clients leave with a documented, individualized medication plan that transfers cleanly to outpatient care in Palm Beach Gardens or wherever they land.

Palm Beach Gardens sits 25 miles north of RECO Immersive’s Delray Beach residential campus — roughly 35 minutes on I-95 outside of peak season. For residents of PGA National, BallenIsles, Mirasol, Frenchman’s Reserve, and Old Palm, that drive opens access to a category of psychiatric pharmacology that outpatient practices in northern Palm Beach County are not structured to deliver: continuous psychiatric presence rather than a 20-minute medication check every four weeks, with dose decisions anchored to observed response rather than self-report.

What observed adherence changes about medication management

In outpatient psychiatric practice, adherence is inferred — from pill counts, from pharmacy refill data, from the client’s own report at the next visit. Clinical decisions that follow are only as reliable as those inferences. If a client stops taking lithium three days into a trial because of tremor, an outpatient prescriber may not learn that until the next appointment two or four weeks later. By then the therapeutic trial hasn’t happened; only the discontinuation has, and the next agent is being selected against incomplete data.

In RECO Immersive’s residential setting, every dose is witnessed by nursing staff. That is not an administrative distinction — it is what allows psychiatry to adjust doses on the basis of actual pharmacologic response. For medications with narrow therapeutic windows — lithium, valproate, lamotrigine during titration, clozapine where used — this changes what psychiatry can measurably know inside a two- or three-week residential window.

The same principle applies to side-effect surveillance. Nausea from sertraline, akathisia from aripiprazole, sedation from quetiapine, metabolic concern on olanzapine — in outpatient care these often surface only when they have already driven the client off the medication. In residential, they surface within 48 to 72 hours and get addressed at the next round: dose split, timing changed, agent swapped, or a PRN added. Trials that would have failed on tolerability get a second chance at efficacy.

Comprehensive lab monitoring during the residential stay

Baseline labs on admission include CBC, complete metabolic panel, TSH, B12 and folate, vitamin D, lipid panel, HbA1c, urine drug screen, and urine pregnancy testing where indicated. Prior treatment records, when available, are reviewed for previous mood stabilizer and antipsychotic trials and for the lab-derived reasons those medications were stopped or changed.

Medication-specific monitoring runs on the residential cadence rather than the outpatient calendar. Lithium levels are drawn weekly during titration and rechecked before discharge. Valproate levels follow a similar rhythm to therapeutic serum concentration. Metabolic panels are repeated at admission and discharge for clients on second-generation antipsychotics — olanzapine, quetiapine, risperidone — with lipid and HbA1c trends documented for outpatient follow-through. EKG is obtained where cardiovascular risk, prior QTc concern, or specific agents (ziprasidone, high-dose citalopram, methadone in dual-diagnosis contexts) warrant it.

Instrument-based tracking during the stay — PHQ-9 for depression, GAD-7 for anxiety, PCL-5 for PTSD, YBOCS where OCD symptoms are present, ASRS for adult ADHD — anchors medication decisions to measured symptom change rather than to clinical impression alone. The receiving outpatient prescriber inherits a documented, lab- and scale-anchored picture of what was done and what to monitor next.

Coordination with concurrent interventional treatment

For residential clients undergoing concurrent transcranial magnetic stimulation or ketamine at RECO Health, the medication regimen is not managed on a parallel track — it is coordinated inside a single treatment plan. Oral antidepressant adherence during a six-week rTMS course (roughly 3,000 pulses per session at 120% of resting motor threshold, delivered on weekdays) matters because the interventional gain compounds against a stable pharmacologic baseline. Interrupting sertraline in the middle of an rTMS series creates confounds that neither treatment can be cleanly evaluated against.

The same integration applies to intranasal esketamine and to racemic ketamine infusion protocols. Benzodiazepine load, current mood stabilizers, and antihypertensives are reviewed before each session; the psychiatric plan accounts for the interventional day-of medication holds where indicated and for the pharmacologic consolidation of ketamine response in the days that follow. The psychiatry team runs both tracks rather than negotiating across two independent prescribers and hoping the plans are compatible.

The medication plan the client leaves with

Discharge from RECO Immersive includes a documented psychiatric medication management plan — current regimen, dosing rationale, prior trials and why they failed, next-step contingencies if partial response persists, and the monitoring schedule the outpatient team should maintain. The plan travels with the client to the RECO Health outpatient team when that is the disposition, or to a home-community prescriber in Palm Beach Gardens, Jupiter, or Palm Beach County more broadly.

Concretely, the discharge summary specifies what agent, what dose, what timing, what to watch for, and what the next decision point is. If the client is stable on lithium 900 mg nightly with a level of 0.7 mEq/L and a normal TSH, that is stated. If the plan calls for a lamotrigine cross-titration should depressive symptoms recur, that is stated. If naltrexone has been initiated for co-occurring alcohol use disorder, the injectable versus oral decision and the next injection date are documented.

That handoff clarity is what allows the pharmacologic gains made in residential to hold in outpatient care. Clients who leave without knowing why they are on what they are on tend not to stay on it. Clients who leave with a written, individualized rationale — and a scheduled outpatient follow-up already in place — carry the residential work forward.

What to expect on the first day

The admission day for a Palm Beach Gardens resident begins with intake at Delray. Psychiatric evaluation covers current symptoms, prior diagnoses and treatment history, prior medication trials and the specific reasons each was discontinued, substance use history, medical comorbidities, and current suicide or self-harm risk. Screening instruments — PHQ-9, GAD-7, and where indicated PCL-5, YBOCS, and ASRS — establish the baseline severity that later decisions will be measured against.

Where alcohol or benzodiazepine withdrawal is a concern, CIWA-Ar governs the first 72 hours; opioid withdrawal is scored with COWS and managed with buprenorphine induction per protocol where clinically appropriate. ASAM Criteria dimensions inform the level-of-care decision at intake and any subsequent step-down. Group programming — CBT, DBT skills, ACT, and MI as clinically indicated — begins as soon as the client is medically able to participate.

Insurance and admissions from Palm Beach Gardens

RECO Immersive works with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans, in-network or out-of-network depending on the specific policy. Verification of benefits is completed before admission. A case manager returns the residential per-diem, the expected authorization length, and the projected out-of-pocket cost given the client’s current deductible and coinsurance status — so the family is not left to interpret those numbers on their own.

From Palm Beach Gardens the drive is 25 miles south on I-95, roughly 35 minutes outside of peak season traffic. Admissions can arrange transportation for intake where indicated. Family therapy sessions and discharge planning meetings are scheduled with the understanding that most families will be commuting from North County, and evening or weekend slots are reserved where work schedules require them.

Serving residents of: BallenIsles, Frenchman's Reserve, Mirasol, Old Palm, PGA National.

Common questions

From Palm Beach Gardens callers, most asked.

Does RECO Immersive accept Florida Blue and Aetna for Palm Beach Gardens residents?
RECO Immersive works with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans, in-network or out-of-network depending on the specific policy. Palm Beach Gardens residents typically hold commercial group plans through Gardens-area employers or a Medicare Advantage supplement — both are handled by admissions through a full verification of benefits before intake. That verification returns the residential per-diem, an expected authorization length, and the projected out-of-pocket cost given current deductible and coinsurance status. Coverage decisions are not left to the family to reconstruct from a summary of benefits.
How long is the residential stay for medication management?
Length of stay is driven by clinical need rather than by a fixed program calendar. A pharmacology-focused admission — lithium initiation, cross-titration off a failed agent, stabilization on a mood stabilizer with therapeutic level confirmation — typically runs 21 to 45 days, longer where co-occurring substance use, trauma treatment, or medical complexity extends the clinical work. Discharge is timed to a stable regimen, a documented follow-up, and a completed transition plan, not to a preset number of days. Length of stay is reauthorized on a rolling basis with the insurer as clinical justification supports.
What happens on the first day of residential admission?
The admission day begins with intake, a comprehensive psychiatric evaluation, medication reconciliation, and baseline labs — CBC, CMP, TSH, B12/folate, lipid panel, HbA1c, urine drug screen, and pregnancy testing where indicated. Structured instruments (PHQ-9, GAD-7, PCL-5, YBOCS, ASRS as indicated) establish baseline severity for later comparison. Where withdrawal risk is present, CIWA-Ar or COWS scoring governs the first 72 hours and dictates the detoxification protocol, including buprenorphine induction for opioid use disorder where clinically appropriate. Family collateral is obtained the same day with the client's consent.
How is psychiatric medication management different in residential than in outpatient care?
In outpatient psychiatry, adherence is inferred from pill counts, refill data, and the client's self-report at the next 20-minute med check. In residential, every dose is observed by nursing, side effects are captured within 48 to 72 hours, and dose adjustments are made against actual response rather than approximation. That structural difference is what makes residential the setting of choice for narrow-therapeutic-window medications (lithium, valproate, lamotrigine titration), for clients whose prior outpatient trials failed on side effects rather than on efficacy, and for regimen simplification where polypharmacy has accumulated over years of piecemeal outpatient adjustment. Instrument-based measurement (PHQ-9, GAD-7, YBOCS) anchors the decisions rather than clinical impression alone.
How do I get to RECO Immersive from Palm Beach Gardens?
RECO Immersive's residential campus is 25 miles south of Palm Beach Gardens in Delray Beach, roughly 35 minutes on I-95 outside of peak season. Most families driving from PGA National, BallenIsles, Mirasol, or Frenchman's Reserve take I-95 south to the Atlantic Avenue or Linton Boulevard exits and continue east. Admissions can arrange transportation for the initial intake where indicated, and family therapy sessions and discharge planning meetings are scheduled with the understanding that most families will be commuting from North County. Evening and weekend slots are reserved where work schedules require them.
How is family involved during residential treatment?
Family involvement follows the client's written consent under HIPAA and, where applicable, 42 CFR Part 2 protections for substance use disorder records. When consent is in place, family therapy sessions are scheduled during the stay, and family members receive psychoeducation on the specific diagnoses, medications, and treatment plan under way. Discharge planning includes family in the transition conversation — what the medication regimen is, what warning signs matter, and what the outpatient follow-up structure looks like. Where family dynamics are a driver of relapse, structured family work with a licensed clinician is written into the plan rather than left as optional.
Start admissions

Confidential. No commitment.

Tell us a little and a real human from admissions will call you back. We verify insurance benefits within minutes and tell you honestly whether RECO Immersive is the right fit — including if we should refer you elsewhere.

Carriers commonly used in Palm Beach Gardens:
Florida Blue Aetna Cigna UnitedHealthcare Humana BCBS
Take the next step

When you’re ready, we’re here.

(561) 464-4077
Start AdmissionsSend a Message